RT Journal Article
SR Electronic
T1 Uncovering social states in healthy and clinical populations using digital phenotyping and Hidden Markov Models
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.06.07.24308598
DO 10.1101/2024.06.07.24308598
A1 Leaning, Imogen E.
A1 Costanzo, Andrea
A1 Jagesar, Raj
A1 Reus, Lianne M.
A1 Visser, Pieter Jelle
A1 Kas, Martien J.H.
A1 Beckmann, Christian
A1 Ruhé, Henricus G.
A1 Marquand, Andre F.
YR 2024
UL http://medrxiv.org/content/early/2024/06/08/2024.06.07.24308598.abstract
AB Brain related disorders are characterised by observable behavioural symptoms. Smartphones can passively collect objective behavioural data, avoiding recall bias. Despite promising clinical utility, analysing smartphone data is challenging as datasets often include a range of missingness-prone temporal features. Hidden Markov Models (HMMs) provide interpretable, lower-dimensional temporal representations of data, allowing missingness. We applied an HMM to an aggregate dataset of smartphone measures designed to assess social functioning in healthy controls (HCs) (n=247), participants with schizophrenia (n=18), Alzheimer’s disease (AD) (n=26) and memory complaints (n=57). We selected a model with socially “active” and “inactive” states, generated hidden state sequences per participant and calculated their “dwell time”, i.e. the percentage of time spent in the socially active state. We identified lower dwell times in AD versus HCs and higher dwell times related to increased social functioning questionnaire scores in HCs, finding the HMM to be a practical method for digital phenotyping analysis.Competing Interest StatementChristian Beckmann is a director of SBGNeuro. Henricus Ruhe received grants from the Hersenstichting, ZonMw, the Dutch Ministry of Health and an unrestricted educational grant from Janssen. In addition he received speaking fees from Lundbeck, Janssen, Benecke and Prelum; all outside the current work.Funding StatementThis study was funded by the European Research Council (consolidator grant 101001118). The Dutch Brain Research Registry (Hersenonderzoek.nl) is supported by ZonMw‐Memorabel (project no 73305095003), Alzheimer Nederland, Amsterdam Neuroscience, and Hersenstichting (Dutch Brain Foundation). The PRISM project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115916. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA. This study reflects only the authors' view and the European Commission is not responsible for any use that may be made of the information it contains.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:For the PRISM dataset, the Ethics Review Board of each of the participating centres in Spain (Hospital General Universitario Gregorio Maranon and Hospital Universitario de La Princesa) and the Netherlands (University Medical Center Utrecht, Leiden University Medical Center and Amsterdam UMC, location VUmc) gave ethical approval for this work. For the Hersenonderzoek dataset, the Ethical Review Board VU University Medical Centre gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe datasets analysed during the current study are available from the corresponding author on reasonable request.